Trial intelligence / Profile preview

Benapenem PK and Tolerability in Healthy Subjects

NCT03578588Phase 1Completed

Sponsor
Sihuan Pharmaceutical
Start
Dec 2015
Primary completion
Jan 2016
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of benapenem in bacterial infection (5 arms), sponsored by Sihuan Pharmaceutical. Primary endpoints: Area Under the Curve (AUC0-24), Maximum observed plasma concentration and 2 more. Started Dec 2015; status: completed.

02

Drugs

benapenem
03

Conditions

bacterial infection

Beyond the preview

Go deeper on NCT03578588.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03578588.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call